The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior

Epigenetics

Volumn 8, Issue 12, 2013, Pages 1321-1329

  Conradt, Elisabeth ^a,b   Lester, Barry M ^a,b   Appleton, Allison A ^c   Armstrong, David A ^c   Marsit, Carmen J ^c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

DNA methylation; Maternal anxiety; Maternal depression; Newborn neurobehavior

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; GLUCOCORTICOID RECEPTOR;

11BETA HYDROXYSTEROID DEHYDROGENASE 2 GENE; ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE; GESTATIONAL AGE; GLUCOCORTICOID RECEPTOR GENE; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOOD DISORDER; MUSCLE HYPOTONIA; NEWBORN; PHONETICS; PLACENTAL DELIVERY; POLYMERASE CHAIN REACTION; PREVALENCE; PSYCHOMETRY; PUERPERAL DEPRESSION; PYROSEQUENCING; SCORING SYSTEM; TOBACCO DEPENDENCE; VAGINAL DELIVERY;

DNA METHYLATION; MATERNAL ANXIETY; MATERNAL DEPRESSION; NEWBORN NEUROBEHAVIOR;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; ANXIETY; DEPRESSION; DNA METHYLATION; FEMALE; FETAL DEVELOPMENT; HUMANS; HYDROCORTISONE; INFANT BEHAVIOR; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; MOOD DISORDERS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, GLUCOCORTICOID;

EID: 84888796582     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26634     Document Type: Article

References (41)

1. Hompes T, Izzi B, Gellens E, Morreels M, Fieuws S, Pexsters A, Schops G, Dom M, Van Bree R, Freson K, et al. Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. J Psychiatr Res 2013; 47:880-91; PMID:23566423; http:// dx.doi.org/10.1016/j.jpsychires.2013.03.009
2. Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 2011; 28:1008-19; PMID:21898709; http://dx.doi.org/10.1002/ da.20883
3. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003; 43:60-6; PMID:12614635; http://dx.doi.org/10.1016/S0018-506X(02)00016-8
4. Field T, Diego M, Dieter J, et al. Prenatal depression effects on the fetus and the newborn. Infant Behav Dev 2004; 27:216-29; PMID:17138297; http:// dx.doi.org/10.1016/j.infbeh.2003.09.010
5. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. Summary (Indianap Ind) 2005
6. Monk C, Spicer J, Champagne FA. Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol 2012; 24:1361-76; PMID:23062303; http://dx.doi.org/10.1017/S0954579412000764
7. Essex MJ, Klein MH, Cho E, Kalin NH. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry 2002; 52:776-84; PMID:12372649; http://dx.doi.org/10.1016/S0006-3223(02)01553-6
8. Sandman CA, Davis EP, Buss C, Glynn LM. Prenatal programming of human neurological function. Int J Pept 2011; 2011:837596; PMID:21760821; http:// dx.doi.org/10.1155/2011/837596
9. Millan MJ. An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy. Neuropharmacology 2012; 68:2-82; PMID:23246909; http://dx.doi.org/10.1016/j. neuropharm.2012.11.015.
10. Sandman CA, Davis EP. Neurobehavioral risk is associated with gestational exposure to stress hormones. Expert Rev Endocrinol Metab 2012; 7:445-59; PMID:23144647; http://dx.doi.org/10.1586/ eem.12.33
11. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab 2001; 86:104-9; PMID:11231985; http://dx.doi. org/10.1210/jc.86.1.104
12. Lundy BL, Jones NA, Field T, et al. Prenatal depression effects on neonates. Infant Behav Dev 1999; 22:119-29; http://dx.doi.org/10.1016/ S0163-6383(99)80009-5
13. Meyer JS. Biochemical effects of corticosteroids on neural tissues. Physiol Rev 1985; 65:946-1020; PMID:2414792
14. Kaplan LA, Evans L, Monk C. Effects of mothers' prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified? Early Hum Dev 2008; 84:249-56; PMID:17761394; http://dx.doi. org/10.1016/j.earlhumdev.2007.06.004
15. Holmes MC, Abrahamsen CT, French KL, Paterson JM, Mullins JJ, Seckl JR. The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J Neurosci 2006; 26:3840-4; PMID:16597738; http://dx.doi. org/10.1523/JNEUROSCI.4464-05.2006
16. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2011; 59:279-89; PMID:20591431; http://dx.doi. org/10.1016/j.yhbeh.2010.06.007
17. Cicchetti D, Toth SL. The development of depression in children and adolescents. Am Psychol 1998; 53:221-41; PMID:9491749; http://dx.doi. org/10.1037/0003-066X.53.2.221
18. Marsit CJ, Maccani MA, Padbury JF, Lester BM. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012; 7:e33794; PMID:22432047; http://dx.doi. org/10.1371/journal.pone.0033794
19. Lester BM, Tronick EZ. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 2004; 113:634-40; PMID:14993523
20. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008; 3:97-106; PMID:18536531; http://dx.doi.org/10.4161/ epi.3.2.6034
21. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008; 28:9055-65; PMID:18768700; http://dx.doi.org/10.1523/ JNEUROSCI.1424-08.2008
22. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-54; PMID:15220929; http://dx.doi.org/10.1038/nn1276
23. Bromer C, Marsit CJ, Armstrong DA, Padbury JF, Lester B. Genetic and epigenetic variation of the glucocorticoid receptor (NR3C1) in placenta and infant neurobehavior. Dev Psychobiol 2012; PMID:22714792; http://dx.doi.org/10.1002/ dev.21061
24. Goodman SH, Gotlib IH. Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev 1999; 106:458-90; PMID:10467895; http://dx.doi.org/10.1037/0033-295X.106.3.458
25. Field T. Infants of depressed mothers. Dev Psychopathol 1992; 4:49-66; http://dx.doi. org/10.1017/S0954579400005551
26. Slone-Wilcoxon J, Redei EE. Maternal-fetal glucocorticoid milieu programs hypothalamic-pituitarythyroid function of adult offspring. Endocrinology 2004; 145:4068-72; PMID:15205378; http://dx.doi. org/10.1210/en.2004-0473
27. Rieger M, Pirke KM, Buske-Kirschbaum A, Wurmser H, Papousek M, Hellhammer DH. Influence of stress during pregnancy on HPA activity and neonatal behavior. Ann N Y Acad Sci 2004; 1032:228-30; PMID:15677416; http://dx.doi.org/10.1196/ annals.1314.026
28. Ellman LM, Schetter CD, Hobel CJ, Chicz-Demet A, Glynn LM, Sandman CA. Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturation. Dev Psychobiol 2008; 50:232-41; PMID:18335490; http://dx.doi. org/10.1002/dev.20293
29. Van den Bergh BR, Mulder EJ, Mennes M, Glover V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev 2005; 29:237-58; PMID:15811496; http://dx.doi.org/10.1016/j.neubiorev.2004.10.007
30. Lester BM, Conradt E, Marsit CJ. Epigenetic basis for the development of depression in children. Clin Obstet Gynecol 2013; 56:556-65; PMID:23751878; http://dx.doi.org/10.1097/GRF.0b013e318299d2a8
31. Feldman R, Eidelman AI. Neonatal state organization, neuromaturation, mother-infant interaction, and cognitive development in small-for-gestationalage premature infants. Pediatrics 2006; 118:e869-78; PMID:16880249; http://dx.doi.org/10.1542/ peds.2005-2040
32. Liu J, Bann C, Lester B, Tronick E, Das A, Lagasse L, Bauer C, Shankaran S, Bada H. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics 2010; 125:e90-8; PMID:19969621; http://dx.doi.org/10.1542/peds.2009-0204
33. Edge D. Ethnicity, psychosocial risk, and perinatal depression--a comparative study among inner-city women in the United Kingdom. J Psychosom Res 2007; 63:291-5; PMID:17719367; http://dx.doi. org/10.1016/j.jpsychores.2007.02.013
34. Leahy-Warren P, McCarthy G, Corcoran P. Postnatal depression in first-time mothers: prevalence and relationships between functional and structural social support at 6 and 12 weeks postpartum. Arch Psychiatr Nurs 2011; 25:174-84; PMID:21621731; http://dx.doi.org/10.1016/j.apnu.2010.08.005
35. Kadivar H, Garvie PA, Sinnock C, Heston JD, Flynn PM. Psychosocial profile of HIV-infected adolescents in a Southern US urban cohort. AIDS Care 2006; 18:544-9; PMID:16831780; http://dx.doi. org/10.1080/13548500500228763
36. Ponder KL, Salisbury A, McGonnigal B, Laliberte A, Lester B, Padbury JF. Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming. Dev Psychobiol 2011; 53:711-23; PMID:21547899; http://dx.doi.org/10.1002/dev.20549
37. Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury JF, Marsit CJ. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol 2013; 381:160-7; PMID:23911897; http://dx.doi. org/10.1016/j.mce.2013.07.024
38. Filiberto AC, Maccani MA, Koestler DC, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, Gagne LA, Marsit CJ. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 2011; 6:566-72; PMID:21521940; http://dx.doi.org/10.4161/ epi.6.5.15236
39. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM. Epigenetic regulation of 11 β-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004; 114:1146-57; PMID:15489962
40. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617-27; PMID:15939839; http://dx.doi.org/10.1001/archpsyc.62.6.617
41. Aiken LS, West SG. Multiple regression: Testing and interpreting interactions. Sage 1991